A new breast cancer drug which has been succesfully trialled in Cornwall could soon be available for women on the NHS. The Royal Cornwall Hospital has been testing the drug, Perjeta, for the past seven years.
It's seen astounding results, with some women's tumours shrinking away. It's now been approved for use in cancer treatment in the UK and is awaiting formal clearance to be used on the NHS. Our Health Correspondent Jacquie Bird reports.
Jenny McCabe was diagnosed with HER2 Positive breast cancer three years ago. She was treated at the Royal Cornwall Hospital where they were carrying out a trial on Perjeta, a new drug for treating her type of cancer.
A new treatment for breast cancer which was tested at the Royal Cornwall Hospital has been authorised by European medical authorities. The drug Perjeta is said to extend survival rates among patients with an advanced form of the disease.